<DOC>
	<DOCNO>NCT00006004</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Combining one drug may kill tumor cell . It yet know combination chemotherapy regimen effective treat non-small cell lung cancer . PURPOSE : Randomized phase II trial compare effectiveness two combination chemotherapy regimens treat patient non-small cell lung cancer .</brief_summary>
	<brief_title>Comparison Two Combination Chemotherapy Regimens Treating Non-small Cell Lung Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Compare overall survival , response rate , time progression patient non-small cell lung cancer treat paclitaxel carboplatin versus gemcitabine cisplatin . - Compare toxicities 2 regimen patient population . OUTLINE : This randomize , multicenter study . Patients stratify accord weight loss past 6 month ( less 5 % v least 5 % ) disease stage ( stage IIIB pleural pericardial effusion pleural implant vs stage IV/recurrent ) . Patients randomize one two treatment arm . - Arm I : Patients receive paclitaxel IV 3 hour follow carboplatin IV 15-30 minute day 1 . - Arm II : Patients receive gemcitabine IV 30 minute day 1 8 follow cisplatin IV 1 hour day 1 . Treatment continue arm every 21 day 6 course absence unacceptable toxicity disease progression . Patients follow every 3 month 2 year , every 6 month 3 year , annually thereafter . PROJECTED ACCRUAL : Approximately 40-90 patient ( 20-45 per arm ) accrue study within 12 month .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically cytologically confirm nonsmall cell lung carcinoma follow subtypes : Squamous cell Adenocarcinoma Large cell anaplastic Bronchioalveolar Nonsmall cell carcinoma otherwise specify No small cell anaplastic element allow Must : Recurrent disease prior radiotherapy surgery OR Stage IV disease distant metastases OR Stage IIIB disease present pleural pericardial effusion CT chest xray pleural implant document pathologically CT chest xray Bidimensionally measurable evaluable disease Brain metastases allow provide clinically stable treatment surgery and/or radiotherapy PATIENT CHARACTERISTICS : Age : 18 Performance status : ECOG 2 Life expectancy : Not specify Hematopoietic : Absolute neutrophil count least 1,500/mm3 Platelet count least 100,000/mm3 Hepatic : Bilirubin great 1.5 mg/dL SGOT great 5 time upper limit normal Renal : Creatinine great 1.5 mg/dL OR Creatinine clearance least 60 mL/min Cardiovascular : No uncontrolled high blood pressure , unstable angina , congestive heart failure No myocardial infarction within past 6 month No serious ventricular arrhythmia require medication Other : Not pregnant nursing Fertile patient must use effective contraception No active malignancy require ongoing treatment No uncontrolled serious active infection No suspected hypersensitivity agent utilize Cremophor No evidence neuropathy grade 2 great history physical examination PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : No prior chemotherapy nonsmall cell lung cancer Endocrine therapy : Not specify Radiotherapy : See Disease Characteristics No prior radiotherapy site measurable evaluable disease unless subsequent progression document physical exam , radiograph , pathology Recovered prior radiotherapy No concurrent radiotherapy except whole brain radiation develop brain metastasis Surgery : See Disease Characteristics</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>recurrent non-small cell lung cancer</keyword>
	<keyword>squamous cell lung cancer</keyword>
	<keyword>large cell lung cancer</keyword>
	<keyword>stage IIIB non-small cell lung cancer</keyword>
	<keyword>stage IV non-small cell lung cancer</keyword>
	<keyword>adenocarcinoma lung</keyword>
	<keyword>adenosquamous cell lung cancer</keyword>
	<keyword>bronchoalveolar cell lung cancer</keyword>
</DOC>